Aytu BioPharma Inc.

AYTU | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.12

$0 (0.00%)

At close: Sep 21, 2026, 4:00 PM ET

$2.19

+$0.07 (+3.30%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 26, 2026

33.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $22.81M

1D Range

2.10 2.20

52W Range

1.65 3.07

Valuation (TTM)

PE -0.46

PB 0.65

EV/EBITDA 0.08

Valuation (NTM)

Forward PE 117.50

Forward PEG 0.00

Price Target $10.75

Cash Flow

FCF Yield 7.2%

SBC Adj. FCF Yield 5.5%

SBC Impact -24.1%

Margins

Gross Margin 62.5%

Operating Margin -26.8%

FCF Margin 2.9%

Growth (CAGR)

Revenue 3Y | 5Y -18.4% | -0.1%

Dil EPS 3Y | 5Y -36.9% | 96.2%

FCF 3Y | 5Y -246.1% | 82.7%

Returns

ROA -30.5%

ROE -148.9%

ROIC -23.6%

Financial Health

Net Cash

$15.31M

Current Ratio 1.12

Interest Coverage -6.76

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international m...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 83

IPO Date Sep 24, 2008

Website aytubio.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Sep 22, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$10.75

Upside

+407.08%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞